CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.5. COVID-19 Impact Analysis on the market
3.6. Average Selling Price
3.7. Brand Share Analysis
3.8. Key Regulation Analysis
3.9. Market Share Analysis
3.10. Patent Landscape
3.11. Regulatory Guidelines
3.12. Value Chain Analysis
CHAPTER 4: PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Leaf-based
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Seed-Based
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Fruit-based
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
4.5. Others
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market share analysis by country
CHAPTER 5: PLANT-BASED BIOLOGICS MARKET, BY SOURCE
5.1. Overview
5.1.1. Market size and forecast
5.2. Carrot
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Tobacco
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Rice
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Duckweed
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
5.6. Others
5.6.1. Key market trends, growth factors and opportunities
5.6.2. Market size and forecast, by region
5.6.3. Market share analysis by country
CHAPTER 6: PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE
6.1. Overview
6.1.1. Market size and forecast
6.2. Gaucher Disease
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Fabry Disease
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Others
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: PLANT-BASED BIOLOGICS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key trends and opportunities
7.2.2. Market size and forecast, by Product Type
7.2.3. Market size and forecast, by Source
7.2.4. Market size and forecast, by Target Disease
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Key market trends, growth factors and opportunities
7.2.5.1.2. Market size and forecast, by Product Type
7.2.5.1.3. Market size and forecast, by Source
7.2.5.1.4. Market size and forecast, by Target Disease
7.2.5.2. Canada
7.2.5.2.1. Key market trends, growth factors and opportunities
7.2.5.2.2. Market size and forecast, by Product Type
7.2.5.2.3. Market size and forecast, by Source
7.2.5.2.4. Market size and forecast, by Target Disease
7.2.5.3. Mexico
7.2.5.3.1. Key market trends, growth factors and opportunities
7.2.5.3.2. Market size and forecast, by Product Type
7.2.5.3.3. Market size and forecast, by Source
7.2.5.3.4. Market size and forecast, by Target Disease
7.3. Europe
7.3.1. Key trends and opportunities
7.3.2. Market size and forecast, by Product Type
7.3.3. Market size and forecast, by Source
7.3.4. Market size and forecast, by Target Disease
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Key market trends, growth factors and opportunities
7.3.5.1.2. Market size and forecast, by Product Type
7.3.5.1.3. Market size and forecast, by Source
7.3.5.1.4. Market size and forecast, by Target Disease
7.3.5.2. UK
7.3.5.2.1. Key market trends, growth factors and opportunities
7.3.5.2.2. Market size and forecast, by Product Type
7.3.5.2.3. Market size and forecast, by Source
7.3.5.2.4. Market size and forecast, by Target Disease
7.3.5.3. France
7.3.5.3.1. Key market trends, growth factors and opportunities
7.3.5.3.2. Market size and forecast, by Product Type
7.3.5.3.3. Market size and forecast, by Source
7.3.5.3.4. Market size and forecast, by Target Disease
7.3.5.4. Spain
7.3.5.4.1. Key market trends, growth factors and opportunities
7.3.5.4.2. Market size and forecast, by Product Type
7.3.5.4.3. Market size and forecast, by Source
7.3.5.4.4. Market size and forecast, by Target Disease
7.3.5.5. Italy
7.3.5.5.1. Key market trends, growth factors and opportunities
7.3.5.5.2. Market size and forecast, by Product Type
7.3.5.5.3. Market size and forecast, by Source
7.3.5.5.4. Market size and forecast, by Target Disease
7.3.5.6. Rest of Europe
7.3.5.6.1. Key market trends, growth factors and opportunities
7.3.5.6.2. Market size and forecast, by Product Type
7.3.5.6.3. Market size and forecast, by Source
7.3.5.6.4. Market size and forecast, by Target Disease
7.4. Asia-Pacific
7.4.1. Key trends and opportunities
7.4.2. Market size and forecast, by Product Type
7.4.3. Market size and forecast, by Source
7.4.4. Market size and forecast, by Target Disease
7.4.5. Market size and forecast, by country
7.4.5.1. China
7.4.5.1.1. Key market trends, growth factors and opportunities
7.4.5.1.2. Market size and forecast, by Product Type
7.4.5.1.3. Market size and forecast, by Source
7.4.5.1.4. Market size and forecast, by Target Disease
7.4.5.2. Japan
7.4.5.2.1. Key market trends, growth factors and opportunities
7.4.5.2.2. Market size and forecast, by Product Type
7.4.5.2.3. Market size and forecast, by Source
7.4.5.2.4. Market size and forecast, by Target Disease
7.4.5.3. India
7.4.5.3.1. Key market trends, growth factors and opportunities
7.4.5.3.2. Market size and forecast, by Product Type
7.4.5.3.3. Market size and forecast, by Source
7.4.5.3.4. Market size and forecast, by Target Disease
7.4.5.4. South Korea
7.4.5.4.1. Key market trends, growth factors and opportunities
7.4.5.4.2. Market size and forecast, by Product Type
7.4.5.4.3. Market size and forecast, by Source
7.4.5.4.4. Market size and forecast, by Target Disease
7.4.5.5. Australia
7.4.5.5.1. Key market trends, growth factors and opportunities
7.4.5.5.2. Market size and forecast, by Product Type
7.4.5.5.3. Market size and forecast, by Source
7.4.5.5.4. Market size and forecast, by Target Disease
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Key market trends, growth factors and opportunities
7.4.5.6.2. Market size and forecast, by Product Type
7.4.5.6.3. Market size and forecast, by Source
7.4.5.6.4. Market size and forecast, by Target Disease
7.5. LAMEA
7.5.1. Key trends and opportunities
7.5.2. Market size and forecast, by Product Type
7.5.3. Market size and forecast, by Source
7.5.4. Market size and forecast, by Target Disease
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Key market trends, growth factors and opportunities
7.5.5.1.2. Market size and forecast, by Product Type
7.5.5.1.3. Market size and forecast, by Source
7.5.5.1.4. Market size and forecast, by Target Disease
7.5.5.2. UAE
7.5.5.2.1. Key market trends, growth factors and opportunities
7.5.5.2.2. Market size and forecast, by Product Type
7.5.5.2.3. Market size and forecast, by Source
7.5.5.2.4. Market size and forecast, by Target Disease
7.5.5.3. Saudi Arabia
7.5.5.3.1. Key market trends, growth factors and opportunities
7.5.5.3.2. Market size and forecast, by Product Type
7.5.5.3.3. Market size and forecast, by Source
7.5.5.3.4. Market size and forecast, by Target Disease
7.5.5.4. South Africa
7.5.5.4.1. Key market trends, growth factors and opportunities
7.5.5.4.2. Market size and forecast, by Product Type
7.5.5.4.3. Market size and forecast, by Source
7.5.5.4.4. Market size and forecast, by Target Disease
7.5.5.5. Rest of LAMEA
7.5.5.5.1. Key market trends, growth factors and opportunities
7.5.5.5.2. Market size and forecast, by Product Type
7.5.5.5.3. Market size and forecast, by Source
7.5.5.5.4. Market size and forecast, by Target Disease
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2021
CHAPTER 9: COMPANY PROFILES
9.1. Leaf Expression Systems
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.2. Zea Biosciences
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.3. Planet Biotechnology Inc.
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.4. InVitria
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.5. plantform corporation
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.6. IBIO, Inc.
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.7. Mapp Biopharmaceutical, Inc.
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.8. Ventria Bioscience Inc.
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.9. Medicago Inc.
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.10. Eleva GmbH
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
TABLE 01. GLOBAL PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 02. PLANT-BASED BIOLOGICS MARKET FOR LEAF-BASED, BY REGION, 2021-2031 ($MILLION)
TABLE 03. PLANT-BASED BIOLOGICS MARKET FOR SEED-BASED, BY REGION, 2021-2031 ($MILLION)
TABLE 04. PLANT-BASED BIOLOGICS MARKET FOR FRUIT-BASED, BY REGION, 2021-2031 ($MILLION)
TABLE 05. PLANT-BASED BIOLOGICS MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 06. GLOBAL PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 07. PLANT-BASED BIOLOGICS MARKET FOR CARROT, BY REGION, 2021-2031 ($MILLION)
TABLE 08. PLANT-BASED BIOLOGICS MARKET FOR TOBACCO, BY REGION, 2021-2031 ($MILLION)
TABLE 09. PLANT-BASED BIOLOGICS MARKET FOR RICE, BY REGION, 2021-2031 ($MILLION)
TABLE 10. PLANT-BASED BIOLOGICS MARKET FOR DUCKWEED, BY REGION, 2021-2031 ($MILLION)
TABLE 11. PLANT-BASED BIOLOGICS MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 12. GLOBAL PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
TABLE 13. PLANT-BASED BIOLOGICS MARKET FOR GAUCHER DISEASE, BY REGION, 2021-2031 ($MILLION)
TABLE 14. PLANT-BASED BIOLOGICS MARKET FOR FABRY DISEASE, BY REGION, 2021-2031 ($MILLION)
TABLE 15. PLANT-BASED BIOLOGICS MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 16. PLANT-BASED BIOLOGICS MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 17. NORTH AMERICA PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 18. NORTH AMERICA PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 19. NORTH AMERICA PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
TABLE 20. NORTH AMERICA PLANT-BASED BIOLOGICS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 21. U.S. PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 22. U.S. PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 23. U.S. PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
TABLE 24. CANADA PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 25. CANADA PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 26. CANADA PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
TABLE 27. MEXICO PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 28. MEXICO PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 29. MEXICO PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
TABLE 30. EUROPE PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 31. EUROPE PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 32. EUROPE PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
TABLE 33. EUROPE PLANT-BASED BIOLOGICS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 34. GERMANY PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 35. GERMANY PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 36. GERMANY PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
TABLE 37. UK PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 38. UK PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 39. UK PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
TABLE 40. FRANCE PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 41. FRANCE PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 42. FRANCE PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
TABLE 43. SPAIN PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 44. SPAIN PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 45. SPAIN PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
TABLE 46. ITALY PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 47. ITALY PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 48. ITALY PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
TABLE 49. REST OF EUROPE PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 50. REST OF EUROPE PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 51. REST OF EUROPE PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
TABLE 52. ASIA-PACIFIC PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 53. ASIA-PACIFIC PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 54. ASIA-PACIFIC PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
TABLE 55. ASIA-PACIFIC PLANT-BASED BIOLOGICS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 56. CHINA PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 57. CHINA PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 58. CHINA PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
TABLE 59. JAPAN PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 60. JAPAN PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 61. JAPAN PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
TABLE 62. INDIA PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 63. INDIA PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 64. INDIA PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
TABLE 65. SOUTH KOREA PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 66. SOUTH KOREA PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 67. SOUTH KOREA PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
TABLE 68. AUSTRALIA PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 69. AUSTRALIA PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 70. AUSTRALIA PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
TABLE 71. REST OF ASIA-PACIFIC PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 72. REST OF ASIA-PACIFIC PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 73. REST OF ASIA-PACIFIC PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
TABLE 74. LAMEA PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 75. LAMEA PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 76. LAMEA PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
TABLE 77. LAMEA PLANT-BASED BIOLOGICS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 78. BRAZIL PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 79. BRAZIL PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 80. BRAZIL PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
TABLE 81. UAE PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 82. UAE PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 83. UAE PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
TABLE 84. SAUDI ARABIA PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 85. SAUDI ARABIA PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 86. SAUDI ARABIA PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
TABLE 87. SOUTH AFRICA PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 88. SOUTH AFRICA PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 89. SOUTH AFRICA PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
TABLE 90. REST OF LAMEA PLANT-BASED BIOLOGICS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 91. REST OF LAMEA PLANT-BASED BIOLOGICS MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 92. REST OF LAMEA PLANT-BASED BIOLOGICS MARKET, BY TARGET DISEASE, 2021-2031 ($MILLION)
TABLE 93. LEAF EXPRESSION SYSTEMS: KEY EXECUTIVES
TABLE 94. LEAF EXPRESSION SYSTEMS: COMPANY SNAPSHOT
TABLE 95. ZEA BIOSCIENCES: KEY EXECUTIVES
TABLE 96. ZEA BIOSCIENCES: COMPANY SNAPSHOT
TABLE 97. PLANET BIOTECHNOLOGY INC.: KEY EXECUTIVES
TABLE 98. PLANET BIOTECHNOLOGY INC.: COMPANY SNAPSHOT
TABLE 99. INVITRIA: KEY EXECUTIVES
TABLE 100. INVITRIA: COMPANY SNAPSHOT
TABLE 101. PLANTFORM CORPORATION: KEY EXECUTIVES
TABLE 102. PLANTFORM CORPORATION: COMPANY SNAPSHOT
TABLE 103. IBIO, INC.: KEY EXECUTIVES
TABLE 104. IBIO, INC.: COMPANY SNAPSHOT
TABLE 105. MAPP BIOPHARMACEUTICAL, INC.: KEY EXECUTIVES
TABLE 106. MAPP BIOPHARMACEUTICAL, INC.: COMPANY SNAPSHOT
TABLE 107. VENTRIA BIOSCIENCE INC.: KEY EXECUTIVES
TABLE 108. VENTRIA BIOSCIENCE INC.: COMPANY SNAPSHOT
TABLE 109. MEDICAGO INC.: KEY EXECUTIVES
TABLE 110. MEDICAGO INC.: COMPANY SNAPSHOT
TABLE 111. ELEVA GMBH: KEY EXECUTIVES
TABLE 112. ELEVA GMBH: COMPANY SNAPSHOT
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
